scispace - formally typeset
Search or ask a question
Author

Frederick J. Schoen

Bio: Frederick J. Schoen is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart valve & Calcification. The author has an hindex of 102, co-authored 434 publications receiving 42611 citations. Previous affiliations of Frederick J. Schoen include Beth Israel Deaconess Medical Center & Emory University.


Papers
More filters
Book
11 Oct 1996
TL;DR: A. Ratner, Biomaterials Science: An Interdisciplinary Endeavor, Materials Science and Engineering--Properties of Materials: J.E. Schoen, and R.J.Ratner, Surface Properties of Materials, and Application of Materials in Medicine and Dentistry.
Abstract: B.D. Ratner, Biomaterials Science: An Interdisciplinary Endeavor. Materials Science and Engineering--Properties of Materials: J.E. Lemons, Introduction. F.W. Cooke, Bulk Properties of Materials. B.D. Ratner, Surface Properties of Materials. Classes of Materials Used in Medicine: A.S. Hoffman, Introduction. J.B. Brunski, Metals. S.A. Visser, R.W. Hergenrother, and S.L. Cooper, Polymers. N.A. Peppas, Hydrogels. J. Kohnand R. Langer, Bioresorbable and Bioerodible Materials. L.L. Hench, Ceramics, Glasses, and Glass Ceramics. I.V. Yannas, Natural Materials. H. Alexander, Composites. B.D. Ratner and A.S. Hoffman, Thin Films, Grafts, and Coatings. S.W. Shalaby, Fabrics. A.S. Hoffman, Biologically Functional Materials. Biology, Biochemistry, and Medicine--Some Background Concepts: B.D. Ratner, Introduction. T.A. Horbett, Proteins: Structure, Properties, and Adsorption to Surfaces. J.M. Schakenraad, Cells: Their Surfaces and Interactions with Materials. F.J. Schoen, Tissues. Host Reactions to Biomaterials and Their Evaluations: F.J. Schoen, Introduction. J.M. Anderson, Inflammation, Wound Healing, and the Foreign Body Response. R.J. Johnson, Immunology and the Complement System. K. Merritt, Systemic Toxicity and Hypersensitivity. S.R. Hanson and L.A. Harker, Blood Coagulation and Blood-Materials Interaction. F.J.Schoen, Tumorigenesis and Biomaterials. A.G. Gristina and P.T. Naylor, Implant-Associated Infection. Testing Biomaterials: B.D. Ratner, Introduction. S.J. Northup, In Vitro Assessment of Tissue Compatibility. M. Spector and P.A. Lalor, In Vivo Assessment of Tissue Compatibility. S. Hanson and B.D. Ratner, Testing of Blood-Material Interactions. B.H. Vale, J.E. Willson, and S.M. Niemi, Animal Models. Degradation of Materials in the Biological Environment: B.D. Ratner, Introduction. A.J. Coury, Chemical and Biochemical Degradation of Polymers. D.F. Williams and R.L. Williams, Degradative Effects of the Biological Environment on Metals and Ceramics. C.R. McMillin, Mechanical Breakdown in the Biological Environment. Y. Pathak, F.J. Schoen, and R.J. Levy, Pathologic Calcification of Biomaterials. Application of Materials in Medicine and Dentistry: J.E. Lemons, Introduction. D. Didisheim and J.T. Watson, Cardiovascular Applications. S.W. Kim, Nonthrombogenic Treatments and Strategies. J.E. Lemons, Dental Implants. D.C. Smith, Adhesives and Sealants. M.F. Refojo, Ophthalmologic Applications. J.L. Katz, Orthopedic Applications. J. Heller, Drug Delivery Systems. D. Goupil, Sutures. J.B. Kane, R.G. Tompkins, M.L. Yarmush, and J.F. Burke, Burn Dressings. L.S. Robblee and J.D. Sweeney, Bioelectrodes. P. Yager, Biomedical Sensors and Biosensors. Artificial Organs: F.J. Schoen, Introduction. K.D. Murray and D.B. Olsen, Implantable Pneumatic Artificial Hearts. P. Malchesky, Extracorporeal Artificial Organs. Practical Aspects of Biomaterials--Implants and Devices: F.J. Schoen, Introduction. J.B. Kowalski and R.F. Morrissey, Sterilization of Implants. L.M. Graham, D. Whittlesey, and B. Bevacqua, Cardiovascular Implantation. A.N. Cranin, M. Klein, and A. Sirakian, Dental Implantation. S.A. Obstbaum, Ophthalmic Implantation. A.E. Hoffman, Implant and Device Failure. B.D. Ratner, Correlations of Material Surface Properties with Biological Responses. J.M. Anderson, Implant Retrieval and Evaluation. New Products and Standards: J.E. Lemons, Introduction. S.A. Brown, Voluntary Consensus Standards. N.B. Mateo, Product Development and Regulation. B. Ratner, Perspectives and Possibilities in Biomaterials Science. Appendix: S. Slack, Properties of Biological Fluids. Subject Index.

4,194 citations

Journal ArticleDOI
TL;DR: Left ventricular dysfunction might be due, in part, to direct cardiomyocyte toxicity, exacerbated by hypertension, and patients treated with sunitinib should be closely monitored for hypertension and LVEF reduction, especially those with a history of coronary artery disease or cardiac risk factors.

982 citations

Journal ArticleDOI
TL;DR: These experiments provide the first direct evidence from actively contracting human myocardium that intracellular Ca2+ handling is abnormal and may cause systolic and diastolic dysfunction in heart failure.
Abstract: Intracellular Ca2+ release and reuptake are essential for contraction and relaxation of normal heart muscle. Intracellular Ca2+ transients were recorded with aequorin during isometric contraction of myocardium from patients with end-stage heart failure. In contrast to controls, contractions and Ca2+ transients of muscles from failing hearts were markedly prolonged, and the Ca2+ transients exhibited 2 distinct components. Muscles from failing hearts showed a diminished capacity to restore low resting Ca2+ levels during diastole. These experiments provide the first direct evidence from actively contracting human myocardium that intracellular Ca2+ handling is abnormal and may cause systolic and diastolic dysfunction in heart failure.

962 citations

Journal ArticleDOI
TL;DR: Results indicate that EPCs can function similarly to arterial endothelial cells and thereby confer longer vascular-graft survival and might have other general applications for tissue-engineered structures and in treating vascular diseases.
Abstract: Arterial conduits are increasingly preferred for surgical bypass because of inherent functional properties conferred by arterial endothelial cells, especially nitric oxide production in response to physiologic stimuli Here we tested whether endothelial progenitor cells (EPCs) can replace arterial endothelial cells and promote patency in tissue-engineered small-diameter blood vessels (4 mm) We isolated EPCs from peripheral blood of sheep, expanded them ex vivo and then seeded them on decellularized porcine iliac vessels EPC-seeded grafts remained patent for 130 days as a carotid interposition graft in sheep, whereas non-seeded grafts occluded within 15 days The EPC-explanted grafts exhibited contractile activity and nitric-oxide-mediated vascular relaxation that were similar to native carotid arteries These results indicate that EPCs can function similarly to arterial endothelial cells and thereby confer longer vascular-graft survival Due to their unique properties, EPCs might have other general applications for tissue-engineered structures and in treating vascular diseases

888 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: Attention is focussed on the ROS/RNS-linked pathogenesis of cancer, cardiovascular disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes mellitus, neurodegenerative diseases, rheumatoid arthritis, and ageing.

12,240 citations

Journal ArticleDOI
19 Oct 2007-Science
TL;DR: Inspired by the composition of adhesive proteins in mussels, dopamine self-polymerization is used to form thin, surface-adherent polydopamine films onto a wide range of inorganic and organic materials, including noble metals, oxides, polymers, semiconductors, and ceramics.
Abstract: We report a method to form multifunctional polymer coatings through simple dip-coating of objects in an aqueous solution of dopamine. Inspired by the composition of adhesive proteins in mussels, we used dopamine self-polymerization to form thin, surface-adherent polydopamine films onto a wide range of inorganic and organic materials, including noble metals, oxides, polymers, semiconductors, and ceramics. Secondary reactions can be used to create a variety of ad-layers, including self-assembled monolayers through deposition of long-chain molecular building blocks, metal films by electroless metallization, and bioinert and bioactive surfaces via grafting of macromolecules.

8,669 citations

Journal ArticleDOI
19 Dec 2002-Nature
TL;DR: The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.
Abstract: Abundant data link hypercholesterolaemia to atherogenesis. However, only recently have we appreciated that inflammatory mechanisms couple dyslipidaemia to atheroma formation. Leukocyte recruitment and expression of pro-inflammatory cytokines characterize early atherogenesis, and malfunction of inflammatory mediators mutes atheroma formation in mice. Moreover, inflammatory pathways promote thrombosis, a late and dreaded complication of atherosclerosis responsible for myocardial infarctions and most strokes. The new appreciation of the role of inflammation in atherosclerosis provides a mechanistic framework for understanding the clinical benefits of lipid-lowering therapies. Identifying the triggers for inflammation and unravelling the details of inflammatory pathways may eventually furnish new therapeutic targets.

7,858 citations

Journal ArticleDOI
TL;DR: The transforming growth factor beta (TGF-beta) family of growth factors control the development and homeostasis of most tissues in metazoan organisms and mutations in these pathways are the cause of various forms of human cancer and developmental disorders.
Abstract: The transforming growth factor beta (TGF-beta) family of growth factors control the development and homeostasis of most tissues in metazoan organisms. Work over the past few years has led to the elucidation of a TGF-beta signal transduction network. This network involves receptor serine/threonine kinases at the cell surface and their substrates, the SMAD proteins, which move into the nucleus, where they activate target gene transcription in association with DNA-binding partners. Distinct repertoires of receptors, SMAD proteins, and DNA-binding partners seemingly underlie, in a cell-specific manner, the multifunctional nature of TGF-beta and related factors. Mutations in these pathways are the cause of various forms of human cancer and developmental disorders.

7,710 citations